The impact of long-term targeted therapy with omalizumab (more than 2 years) on the asthma control according to the registry of children with uncontrolled severe persistent asthma (Russian experience)

被引：0
|
作者：
Namazova-Baranova, L. [1 ]
Vishneva, E. [1 ]
Dobrynina, E. [1 ]
Alekseeva, A. [1 ]
Levina, J. [1 ]
Efendieva, K. [1 ]
Kalugina, V [1 ]
Voznesenskaya, N. [1 ]
Selimzyanova, L. [1 ]
Promyslova, E. [1 ]
机构：
[1] Sci Ctr Childrens Hlth, Moscow, Russia
来源：
ALLERGY | 2017年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0976
引用
收藏
页码：559 / 560
页数：2
相关论文
共 50 条
  • [1] THE IMPACT ON LONG-TERM TARGETED THERAPY WITH OMALIZUMAB ON THE QUALITY OF LIFE ACCORDING TO REGISTRY OF CHILDREN WITH UNCONTROLLED SEVERE PERSISTENT ASTHMA (RUSSIAN EXPERIENCE)
    Namazova-Baranova, L.
    Vishneva, E.
    Dobrynina, E.
    Alekseeva, A.
    Levina, J.
    Efendieva, K.
    Smirnov, V
    Antonova, E.
    Voznesenskaya, N.
    Selimzianova, L.
    VALUE IN HEALTH, 2016, 19 (07) : A559 - A559
  • [2] 4-6 years experience of targeted therapy with omalizumab in children with uncontrolled severe persistent asthma
    Vishneva, E.
    Namazova-Baranova, L.
    Dobrynina, E.
    Alekseeva, A.
    Levina, J.
    Efendieva, K.
    Kalugina, V
    Chemakina, D.
    Selimsyanova, L.
    ALLERGY, 2018, 73 : 536 - 536
  • [3] Omalizumab in children with severe uncontrolled asthma: 2 years' clinical experience
    Piquer Gibert, M.
    Dominguez Sanchez, O.
    Giner Munoz, M.
    Plaza Martin, A.
    Martin Mateos, M.
    Lozano, J.
    Lozano, J.
    Alvaro Lozano, M.
    Alvaro Lozano, M.
    ALLERGY, 2010, 65 : 530 - 530
  • [4] The results of long-term dynamic monitoring of children with uncontrolled severe persistent asthma, receiving omalizumab
    Namazova-Baranova, L.
    Vishneva, E.
    Dobrynina, E.
    Alekseeva, A.
    Levina, J.
    Efendieva, K.
    Kalugina, V
    Voznesenskaya, N.
    Selimzyanova, L.
    Promyslova, E.
    ALLERGY, 2017, 72 : 562 - 562
  • [5] The results of four-years monitoring of children receiving omalizumab with uncontrolled severe persistent asthma, (according to the pediatric registry)
    Vishneva, E.
    Namazova-Baranova, L.
    Dobrynina, E.
    Alekseeva, A.
    Levina, J.
    Efendieva, K.
    Kalugina, V
    Chemakina, D.
    Selimsyanova, L.
    ALLERGY, 2018, 73 : 313 - 313
  • [6] The patient registry of children with severe persistent uncontrolled asthma as a tool for long-term dynamic monitoring
    Namazova-Baranova, L.
    Vishneva, E.
    Smirnov, V
    Antonova, E.
    Alekseeva, A.
    Efendieva, K.
    Levina, J.
    Tomilova, A.
    Voznesenskaya, N.
    Muradova, O.
    Volkov, K.
    Barannik, V
    Dobrynina, E.
    Selimzyanova, L.
    Promyslova, E.
    ALLERGY, 2015, 70 : 300 - 300
  • [7] The dynamics of disease control in children with uncontrolled severe persistent asthma receiving omalizumab (based on pediatric registry)
    Namazova-Baranova, L.
    Vishneva, E.
    Dobrynina, E.
    Alekseeva, A.
    Levina, J.
    Efendieva, K.
    Kalugina, V
    Voznesenskaya, N.
    Selimzyanova, L.
    Promyslova, E.
    ALLERGY, 2017, 72 : 560 - 560
  • [8] Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma
    Odajima, Hiroshi
    Ebisawa, Motohiro
    Nagakura, Toshikazu
    Fujisawa, Takao
    Akasawa, Akira
    Ito, Komei
    Doi, Satoru
    Yamaguchi, Koichi
    Katsunuma, Toshio
    Kurihara, Kazuyuki
    Teramoto, Takahide
    Sugai, Kazuko
    Nambu, Mitsuhiko
    Hoshioka, Akira
    Yoshihara, Shigemi
    Sato, Norio
    Seko, Noriko
    Nishima, Sankei
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 106 - 115
  • [9] The impact of targeted therapy in children with uncontrolled allergic persistent severe asthma and nasal polyps
    Vishneva, Elena
    Namazova-Baranova, Leyla
    Dobrynina, Elena
    Alekseeva, Anna
    Levina, Julia
    Efendieva, Kamilla
    Kalugina, Vera
    Selimzianova, Liliia
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] ASSESSMENT OF THE EFFICACY OF THE TWO-YEAR TREATMENT WITH OMALIZUMAB, ACCORDING TO THE PEDIATRIC REGISTRY OF THE CHILDREN WITH SEVERE PERSISTENT UNCONTROLLED ASTHMA
    Namazova-Baranova, L.
    Vishneva, E.
    Dobrynina, E.
    Alekseeva, A.
    Levina, J.
    Efendieva, K.
    Antonova, E.
    Smirnov, V
    Vinyarskaya, I
    Chemakina, D.
    Kalugina, V
    VALUE IN HEALTH, 2017, 20 (09) : A649 - A649
12345